Celsius Commercial Scale Solution

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. We will introduce the content of the revised EU GMP Guidelines Annex 1. While reviewing this content, we aim to deepen the relationship between Sartorius and our customers through mutual understanding, particularly regarding Quality Risk Management (QRM) and Contamination Control Strategy (CCS). Additionally, we will provide information on Sartorius's sterilization validation and the latest information on Extractables and Leachables (E|L), which we hope you will find useful. [Seminar Overview] ▪ Date: December 7 (Thursday) at 3:00 PM (approximately 30 minutes) ▪ Format: Webinar recorded broadcast [Japanese, Free] *We sincerely apologize, but participation from companies in the same industry and email addresses other than those of your organization is not permitted. Thank you for your understanding.

This event has concluded. *Please note that there are currently no plans for on-demand distribution. mRNA pharmaceuticals are attracting attention as a new modality for drug discovery. Sartorius has a wide range of technologies that cover the mRNA manufacturing process, including E. coli culture, pDNA purification, IVT reactions, mRNA purification, and freeze storage. In this forum, we will provide a meaningful discussion platform centered around topics such as "pDNA|mRNA Manufacturing Processes," "Sartorius Manufacturing Platforms," and "Application Examples," inviting guest speakers to give presentations and facilitating questions and interactions from participants. Special Lecture Kazuhisa Uchida, Graduate School, Kobe University Capacity [In-person participation] 35 people *If there are many applications, a lottery will be held. [Online participation] 200 people *Please note that applications from competitors and research companies may be declined in advance.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Freezing, storage, transportation, and thawing are important processes in the manufacturing of biopharmaceuticals. By utilizing the latest single-use technologies, we can implement freezing, thawing, and transportation processes in a robust, safe, and scalable manner. In this first webinar of 2023, we will introduce Sartorius's solution "Celsius" and its features. [Seminar Overview] ▪ Date: January 24, 2023 (Tuesday) from 3:00 PM (approximately 40 minutes) ▪ Method: Webinar recorded broadcast [Japanese, free of charge] *We sincerely apologize, but participation from companies in the same industry and email addresses other than those of your organization is not permitted. Thank you for your understanding.

Participation in this webinar has ended. Those who wish to view it on demand can register through the details and application link. In this webinar, Marion Monstier and Sebastien Chaussin, product managers for freeze-thaw technology, will explain in detail the advantages of single-use containers compared to traditional bottles. They will also clarify important parameters to consider when validating such systems in actual processes. *Additional sessions will be held at times accommodating all time zones. We encourage you to participate and share your feedback. For those who could not attend on the day, a link to the on-demand archive will be sent to registered participants. [Main Learning Points] ▪ Advantages of single-use solutions over bottles ▪ Characteristics of single-use containers that can adapt to existing infrastructure at minimal cost ▪ Confirmation of parameters to consider when selecting single-use containers for freeze-thaw applications